Navigation Links
Raydiance collaborates with Rutgers, MTF to develop innovative tissue processing approaches
Date:11/19/2007

any more are in need. Preparing human tissue grafts is a complex and meticulous process. An important part of our mission is the ability to maximize the number and type of transplanted tissues processed from the gift of donation. We believe the Raydiance technology has the potential to process human tissue much more efficiently, increasing the supply of scarce dermal tissues. This would result in more usable tissue, offering the benefit of better outcomes for more patients.

Scott Davison, President of Raydiance, said, We are delighted to work with Rutgers and MTF on this important project. The Raydiance USP laser platform is unlocking disruptive innovation across a range of industries, from materials science to next generation surgery to genomics. The unique challenges inherent in the way tissue is recovered today makes this is an excellent development category for our laser, one that truly plays to the strengths of Raydiance technology.

The initial phase of the project will focus on demonstrating the feasibility of USP laser processing of donor skin in the following areas:

  • Separation of donor skin layers - Develop non-invasive laser-ablation methods to separate the skins dermal and epidermal layers to improve and increase the usability and viability of limited donor tissues.

  • Surface decontamination Develop non-intrusive sterilization techniques on donor skin and tendons to minimize collateral tissue damage while effectively removing viral or bacterial contamination.

  • Removal of unwanted hairs - Develop a laser destruction method to effectively remove unwanted hair from donor tissue with minimal collateral tissue damage.


'/>"/>

Contact: Carl Blesch
cblesch@ur.rutgers.edu
732-932-7084 x616
Rutgers University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Gender, coupled with diabetes, affects vascular disease development
2. New target for anti-flu drug development
3. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
4. A new radiation therapy treatment developed for head and neck cancer patients
5. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
6. Princeton engineers develop low-cost recipe for patterning microchips
7. M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometrics Solution
8. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
9. UCR engineers to develop new tool to measure how environmental exposures affect health
10. Researchers develop simple method to create natural drug products
11. Researchers developing device to predict proper light exposure for human health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... The concept of "place" is increasingly being considered ... now have a new resource that can help ... have with the places in their lives. ... a new book co-edited by the Pacific Northwest ... a human-centered approach to conservation. The book is ...
(Date:5/21/2013)... Cancers of all types become most deadly when ... cancer has reached this stage, it becomes very difficult ... that can develop. Now, researchers at the University of ... that target lymphoma tumor cells wherever they may be ... oncology in the MU College of Veterinary Medicine, says ...
(Date:5/21/2013)... The American Chemical Society (ACS), the world,s largest ... 246th National Meeting & Exposition, September 8-12, 2013, ... the Indiana Convention Center and at area hotels. ... discoveries that span science,s horizons from astronomy ... broadcast and online journalists a rich assortment of ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2
... for "horizontal" gene transfer, a new study has shown, similar ... become resistant to antibiotics and cause other serious problems. ... Nature , suggests that fungi have the capacity to rapidly ... plants and possibly animals, including humans. They are not ...
... patterned surfaces to influence the development of stem cells. ... many stem-cell biologists, who focus instead on uncovering the ... cells. "The cells are seeing the same soluble ... dictating whether they turn into fat or bone, and ...
... release is available in French . , ... extremely important process for the proper functioning and survival ... of ,cargo, to and from the surface of the ... consequences, leading to numerous diseases such as high cholesterol, ...
Cached Biology News:Fungi can change quickly, pass along infectious ability 2Getting turned on 2Getting turned on 3
(Date:5/21/2013)... Raleigh, NC (PRWEB) May 21, 2013 ... and financial services company for clinical trials, announced ... Aggregate Spend Solutions, LLC. Clinverse’s ClinPay® FLS ... automated investigator payment process. SpendMD ™, ... only complete solution for tracking and reporting transfer ...
(Date:5/21/2013)... , May 21, 2013 According ... Research ( http://www.transparencymarketresearch.com ) "Biochip Products and Services Market ... - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," ... 2011 and is expected to grow at a CAGR ... estimated value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... 21, 2013 Many have long discussed ... to acne. Recently physicians from Clinical Psychiatry.com ... on the skin, and suggested using hypnotherapy ... chemicals produced from stress that cause acne. , Doctors ... feelings acne brings about, stress causes changes in the ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
... BERLIN, July 13 The new ... appearance. An initiative recently,launched by Germany Trade & ... namely industrial biotechnology clusters and,chemical parks, in addition ... Germany,s biotechnology sector by creating new business,opportunities across ...
... Italy, July 13 Health Robotics today announced,that ... channel strategies,with direct investments in local infrastructure at ... distributors have been negatively affected by a,number of ... distributor,s,litigation with investors, and some financial difficulties supporting ...
... NATICK, Mass., July 13 Boston Scientific Corporation ... its LATITUDE(R) Patient Management system. The LATITUDE system remotely ... both the device and a patient,s heart health status. ... visits and send relevant data directly to a patient,s physician. ...
Cached Biology Technology:German Alliance for Industrial Biotechnology Debuts in Montreal 2Health Robotics Expands and Diversifies Global Channel Strategies With Joint-Ventures & Direct Operations 2Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System 2Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System 3Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System 4
BD BioCoat Laminin 150 mm Culture Dishes...
...
The BD CBA Human Apoptosis Kit can be used to quantitatively measure,cleaved PARP, Bcl-2, and active Caspase-3 protein levels in a single sample. The,Kit performance has been optimized for analysis o...
... package that provides crystallographers with an ... creation, set-up of experimental conditions and ... software helps crystallographers through the most ... Design of Crystallization ...
Biology Products: